Coloplast Sets 2030 Organic Revenue Growth and EBIT Margin Targets
Coloplast targets annual organic revenue growth of 5–7% and an EBIT margin in the mid-20% range through 2030.
Related stories
Peruvian Miner Linked to Luksic Family Cuts Gold Production Forecast
The miner cut its gold production projections amid problems at the San Gabriel project.
M impact | EARNINGS | Nov 02, 2026, 06:41 PM UTC
Amadeus Fire Reports Nine-Month Revenue of EUR 261.5 Million
L impact | EARNINGS | Nov 02, 2026, 06:32 PM UTC
Imperial Oil Reports C$16.18B Revenue and C$5.11 EPS for Q3 2026
Imperial Oil reported net income of C$2.45B. Revenue and earnings increased from the prior-year quarter, supported by higher crude realizations and refining margins.
M impact | EARNINGS | Nov 02, 2026, 06:21 PM UTC
How to Spot an Earnings Trade That Costs too Much
Before you tell me a stock is going to explode after earnings, I want to know how much movement the options...
H impact | EARNINGS | Nov 02, 2026, 06:00 PM UTC
Marico Raises Full-Year Growth Targets After Strong Q2
Marico reported a strong July-September quarter and raised its full-year growth targets. The body is truncated before the revised targets are specified.
M impact | EARNINGS | Nov 02, 2026, 05:48 PM UTC
Coloplast Reports 6% Organic Growth for FY 2025/26
Coloplast reported 4% EBIT growth in constant currencies and 4% revenue growth in DKK, including a 2-percentage-point negative currency impact. Prior-period comparisons were not pr
M impact | EARNINGS | Nov 02, 2026, 05:42 PM UTC